Abstract
Embodiments of this invention are directed generally to biology and medicine. In certain aspects, embodiments are directed to compositions and methods related to Tau oligomer specific antibodies.
Original language | English (US) |
---|---|
Patent number | EP2470211B1 |
Filing date | 8/30/10 |
State | Published - Jan 17 2016 |
Keywords
- Alzheimer's disease
- Neurological disorders